Grail (GRAL) Other financing activities (2023 - 2024)

Grail (GRAL) posted Other financing activities of $932.3 million for Q2 2024, up 198.81% quarter-over-quarter from $312.0 million in Q1 2024.

Grail (GRAL) Other financing activities (2023 - 2024) Analysis & Trends

Grail (GRAL) has reported Other financing activities for 2 consecutive years, with $932.3 million the latest figure, recorded in Q2 2024.

Other financing activities for Q2 2024 came in at $932.3 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2025 was $932.3 million (changed N/A YoY), and the FY2024 annual result was $1.2 billion, up 168.17% from the prior year.
Other financing activities was $932.3 million for Q2 2024 at Grail, up from $312.0 million in the prior quarter.
Over five years, Other financing activities peaked at $932.3 million in Q2 2024 and troughed at $86.0 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn
10	Grail	2.77 Bn	1.94 Bn	10.12 Mn

Download Data